Divis Laboratories

BSE : 532488 | NSE : DIVISLAB

Industry : Pharma Drugs | ISIN : INE361B01024 | FreeFloat : 50.00% | FnO : Yes | LotSize : 400


Intellectual Capital (IC)15,911.43
Net Worth (NW)7,437.18
Intrinsic Worth (IW)23,348.61
Market Cap (MC)49,000.19
Economic Value Added130.24
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)68.15%
IC Gross Margin (EBITDA/IC)14.03%
IC Net Margin (NPT/IC)9.30%
Knowledge Turnover (Sales/IC)0.35
Market to Intrinsic Value (MC/IW)2.10

As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 879.52Rs. 1,845.80
29 May 2020 - Rs. 2,390.10
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 2,329.85BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 2,202.46
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
S
1066.67
1087.60
382.93
351.49
350.45
259.29
259.49
Jun-17
S
821.20
850.88
274.50
242.19
241.70
176.54
176.18
Sep-17
S
890.20
923.79
310.79
276.86
276.11
206.78
206.40
Dec-17
S
1037.88
1054.89
343.15
305.76
305.50
224.66
224.29
Mar-18
S
1087.95
1136.12
434.67
395.88
396.05
261.60
263.38
Jun-18
S
995.31
1044.10
400.65
359.05
358.41
266.16
266.33
Sep-18
S
1285.00
1365.05
594.18
551.79
551.55
397.65
397.82
Dec-18
S
1342.92
1377.48
557.89
515.41
512.89
379.49
379.65
Mar-19
S
1256.43
1298.16
452.82
410.48
410.38
289.35
289.90
Jun-19
S
1139.92
1171.55
410.24
366.43
366.11
267.35
267.65
Sep-19
S
1403.92
1451.28
532.72
486.81
483.02
352.83
353.09
Dec-19
S
1390.49
1430.80
537.18
490.49
488.94
360.73
360.91
* C - Consolidated, S - Standalone